Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:01 AM
Ignite Modification Date:
2025-12-25 @ 4:01 AM
NCT ID:
NCT00731302
Eligibility Criteria:
Inclusion Criteria:
* Written Informed consent.
* Age \>18 yrs.
* SLE meeting ACR criteria {Tan, Cohen, et al. 1982 1482 /id} for at least 6 months.(SLE group)
* Stable disease activity as evidenced by no change in immunosuppressive therapy in the past 1 month.
* If female of childbearing potential must use an effective method of birth control
Exclusion criteria.
* Renal disease (creatinine \>1.5 mg/dL, dialysis, 2+ or more proteinuria)
* Previous or current history of peptic ulcer disease or gastrointestinal bleed.
* Previous or current thromboembolic or ischemic cardiovascular event (stroke, myocardial infarction, angina) - can do aspirin part of study.
* Currently taking an anticoagulant or antiplatelet agent (besides aspirin).
* Thrombocytopenia (platelet count \<135,000)
* Pregnancy
* Allergy to aspirin, NSAIDs
* NSAIDs in the previous week
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00731302
Study Brief:
Protocol Section:
NCT00731302